We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Molecular Diagnostics

Image: The AidaBREAST assay integrates multimodal data to provide patient-specific 10-year recurrence risk and individualized predictions of radiation therapy benefit (photo courtesy of PreludeDx)

Validated Test Predicts Recurrence Risk and Radiation Benefit in Early-Stage Breast Cancer

A new multi-omic AI test predicts 10-year locoregional recurrence and radiation benefit in early-stage breast cancer. More...
12 Oct 2026
Image: Natera\'s MCED assay analyzes cell-free DNA in blood to screen for multiple cancers (Image Credit: Adobe Stock)

Multi-Cancer Screening Blood Test Gains FDA Breakthrough Designation

Natera’s  multi-cancer early detection (MCED) assay has received Breakthrough Device designation from the FDA. More...
11 Oct 2026
Photo courtesy of National Human Genome Research Institute

Genomic Screening Expands Detection of Treatable Conditions in Newborns

New data show genomic newborn screening augments standard tests by detecting missed treatable conditions earlier. More...
09 Oct 2026
Image Credit: Adobe Stock

Age-Based Genetic Testing May Miss Most Inherited Cancer Risk Variants

New findings show age-based germline testing misses 72% of pathogenic variants in solid tumors More...
08 Oct 2026
Image: The LymphoTrack Flex suite is an integrated next-generation sequencing solution for identifying and tracking immunoglobulin and T-cell receptor gene rearrangements (Photo courtesy of Invivoscribe)

New NGS Suite Expands Clonality and MRD Research in Lymphoid Malignancies

A new NGS suite integrates clonality, somatic hypermutation, and MRD tracking in lymphoid cancers, boosting sensitivity and scale. More...
08 Oct 2026
Image: Signatera analyzes circulating tumor DNA (ctDNA) to assess molecular residual disease (MRD) (Photo courtesy of Natera)

Tumor-Informed ctDNA Test Shows Utility Across Gastrointestinal and Gynecologic Cancers

New data on Natera's Signatera were presented in four oral presentations at the ASCO 2026 Annual Meeting.  More...
08 Oct 2026
Image: The study was carried out by Start4All, a partnership led by Liverpool School of Tropical Medicine (LSTM) with the Stop TB Partnership and research partners in seven countries with a high TB burden (Photo courtesy of Liverpool School of Tropical Medicine)

Pooled Sputum Testing Offers Lower-Cost Molecular Diagnosis for Tuberculosis

New data show pooled sputum testing halves cartridges and costs for rapid TB diagnosis. More...
08 Oct 2026
Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
NEW PRODUCT : SILICONE WASHING MACHINE TRAY COVER WITH VICOLAB SILICONE NET VICOLAB®
REGISTRED 682.9
Automatic CLIA Analyzer
Shine i6000
Automated Clinical Chemistry Analyzer
Envoy 500+


Genetic Testing channel of LabMedica brings the latest in molecular genetics, cytogenetics, and epigenetics, and methods from PCR to FISH, and more.
Copyright © 2000-2026 Globetech Media. All rights reserved.